Free Trial
LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
1.75
1.75
52-Week Range
N/A
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.50 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
AVO stock logo

About Advanced Oncotherapy Stock (LON:AVO)

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

AVO Stock News Headlines

Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Advanced Oncotherapy raises £2mln at a premium
See More Headlines
Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/29/2020
Today
7/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
Agriculture
CIK
N/A
Fax
N/A
Employees
3,900
Year Founded
N/A

Profitability

Net Income
£-32,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.50 million
Optionable
Not Optionable
Beta
0.06
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Michael Jeffrey Sinclair (Age 82)
    Executive Chairman
    Comp: $434.42k
  • Mr. Nicolas Serandour (Age 49)
    CEO & Executive Director
    Comp: $502.96k
  • Prof. Stephen Myers OBE (Age 78)
    Executive Director
    Comp: $397.72k
  • Mr. Ed Lee
    COO & President of Europe
  • Mr. Graham Pughe
    Senior Vice-President of Accounting
  • Ms. Berengere Pons-Chabord
    Senior Vice-President of Corporate Finance
  • Mr. David Navas
    Vice President of Investor and Public Relations
  • Ms. Bridget Biggar
    Director of Human Resources
  • Ms. Donatella Ungaro
    Managing Director of ADAM
  • Ms. Marina Giunta
    Head of Physics Group

AVO Stock Analysis - Frequently Asked Questions

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) announced its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE) and Sirius Minerals (SXX).

This page (LON:AVO) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners